✦ LIBER ✦

The risk factors for malignancy in surgically treated patients for Graves' disease, toxic multinodular goiter, and toxic adenoma

✍ Scribed by Yasemin Giles (Senyurek); Tunca Fatih; Boztepe Harika; Kapran Yersu; Terzioglu Tarik; Tezelman Serdar

Book ID: 113921019
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 232 KB
Volume: 144
Category: Article
ISSN: 0039-6060
DOI: 10.1016/j.surg.2008.08.022

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Epidermal growth factor receptor polymor

Epidermal growth factor receptor polymorphisms and risk for toxicity in paediatric patients treated with gefitinib

✍ Trevor McKibbin; Wei Zhao; Michael Tagen; Najat C. Daw; Wayne L. Furman; Lisa M. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Tumor ploidy as a risk factor for diseas

Tumor ploidy as a risk factor for disease recurrence and short survival in surgically-treated dukes' B2 colon cancer patients

✍ Dattatreyudu Nori; Ofer Merimsky; Engracio Samala; Dr. Daisy Saw; Engracio Corte 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 360 KB

## Abstract The risk factors for colon cancer recurrence following a curative intent surgery include the presence of metastatic disease, the tumor location and size, number of positive lymph nodes, the presence of adhesions, perforation, bowel obstruction, depth of invasion, histological grade, per

Early relapse and refractory disease rem

Early relapse and refractory disease remain risk factors in the anthracycline and autologous transplant era for patients with relapsed/refractory classical Hodgkin lymphoma: a single centre intention-to-treat analysis

✍ Paul Greaves; Andrew Wilson; Janet Matthews; Daniel L. P. Brown; Rebecca Auer; S 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB

DNA-methylation of the homeodomain trans

DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients – Technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group

✍ Sabine Maier; Inko Nimmrich; Thomas Koenig; Serenella Eppenberger-Castori; Inga 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 621 KB